Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review
Sandra López‐Verdín(Universidad de la República de Uruguay), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Nicolás Serafín‐Higuera(Universidad Autónoma de Baja California), Rogelio González‐González(Universidad de la República de Uruguay), Jesús Lavalle‐Carrasco(Universidad de la República de Uruguay), Ramón Gil Carreón-Burciaga(Universidad de la República de Uruguay), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana)
Cited by 44
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58